Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | UBE2N | P61088 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 8/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27358898 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL4875812 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1147869 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1147850 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL3394794 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1147732 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL8682114 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27645826 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL9137980 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL15016341 | 0.98 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023148208-A1 | GAS LOSS REDUCING ADDITIVE FOR BEVERAGES, A BEVERAGE COMPOSITION INCLUDING THE GAS LOSS REDUCING ADDITIVE AND A METHOD OF REDUCING GAS LOSS FROM A BEVERAGE | GIVAUDAN SA (CH) | 2023-08-10 | — | — | WO | claimed |
| EP-2709462-B1 | OIL OR FAT COMPOSITIONS CONTAINING DIGLYCERIDES | KAO CORP (JP) | 2017-02-22 | — | — | EP | claimed |
| EP-1413291-B1 | Use of 5-Cholesten-3 beta,25-diol-7-one for the treatment of dry skin or scalp | OREAL (FR) | 2006-05-03 | — | — | EP | claimed |
| EP-0207252-B1 | AROMATIC HYDROXY- OR THIOL DERIVATIVES OF CARBONIC-ACID ESTERS AS LIPASE SUBSTRATES | Roche Diagnostics GmbH (DE) | 1992-07-29 | — | — | EP | claimed |
| WO-1990009981-A1 | PREPARATION OF OPTICALLY ACTIVE GLYCEROL DERIVATIVES | ISIS INNOVATION LIMITED (GB) | 1990-09-07 | — | — | WO | claimed |
| US-20240025870-A1 | PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | Synaptogenix, Inc. (US) | 2024-01-25 | — | — | US | disclosed |
| WO-2024005199-A1 | METHOD FOR PRODUCING COMPOSITION COMPRISING EXOSOME, AND COMPOSITION COMPRISING DIACYLGLYCEROL-CONTAINING EXOSOME | ＩＳＭ株式会社 | 2024-01-04 | — | — | WO | disclosed |
| US-11820745-B2 | PKC-activating compounds for the treatment of neurodegenerative diseases | Synaptogenix, Inc. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230365750-A1 | METHOD FOR PRODUCING MALEIMIDE POLYETHYLENE GLYCOL LIPID | NOF CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| WO-2023148208-A1 | GAS LOSS REDUCING ADDITIVE FOR BEVERAGES, A BEVERAGE COMPOSITION INCLUDING THE GAS LOSS REDUCING ADDITIVE AND A METHOD OF REDUCING GAS LOSS FROM A BEVERAGE | GIVAUDAN SA (CH) | 2023-08-10 | — | — | WO | disclosed |
| EP-4219592-A1 | METHOD FOR PRODUCING MALEIMIDE POLYETHYLENE GLYCOL LIPID | NOF Corporation (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-20220356161-A1 | PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | Synaptogenix, Inc. (US) | 2022-11-10 | — | — | US | disclosed |
| US-4847376-A | COLORIMETRIC ANALYSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1989-07-11 | — | — | US | disclosed |
| EP-0284313-A1 | Method for the preparation of a monomolecular film with a symmetrical molecular distribution pattern and use of such a film | K & V LICENCING OY (FI) | 1988-09-28 | — | — | EP | disclosed |
| EP-0228429-A1 | Film aggregate having electrically conducting properties | K & V LICENCING OY (FI) | 1987-07-15 | — | — | EP | disclosed |
| US-4668623-A | Method of fluorometrically measuring the activity of fat-degrading enzymes | KSV-CHEMICALS OY (FI) | 1987-05-26 | — | — | US | disclosed |
| WO-1987000343-A1 | FILM AGGREGATE AND NEW COMPOUNDS THEREFOR | KSV-CHEMICALS OY (FI) | 1987-01-15 | — | — | WO | disclosed |
| EP-0037582-B1 | PROCESS FOR PREPARING 1,2-DIACYL-SN-GLYCEROLS | KSV-Chemicals Oy (FI) | 1983-10-05 | — | — | EP | disclosed |
| US-4360694-A | Process for preparing 1,2-diacyl-sn-glycerols | KSV-CHEMICALS OY (FI) | 1982-11-23 | — | — | US | disclosed |
| EP-0037582-A2 | Process for preparing 1,2-diacyl-SN-glycerols | KSV-Chemicals Oy (FI) | 1981-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220356161-A1 | PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PRKCH, PRKCA, PRKCG | LMNA 1513/4885CYP2D6 3744/4885SPHK1 183/4885 |
| US-11820745-B2 | PKC-activating compounds for the treatment of neurodegenerative diseases | PRKCH, PRKCA, PRKCG | LMNA 1513/4885CYP2D6 3744/4885SPHK1 183/4885 |
| US-20240025870-A1 | PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PRKCH, PRKCA, PRKCG | LMNA 1532/4885CYP2D6 3742/4885SPHK1 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.